Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof

Abstract

This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia . The extract comprises alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, saponins, tannins, acid, flavonoids and others. The composition can be used for treating cancer, arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder, impotence and premature ejaculation; for preventing cerebral aging; for improving memory, cerebral functions; or for curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's disease or other diseases caused by cerebral dysfunctions, and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder. This invention provides compounds comprising at least one sugar, a triterpene, such as Sapogenin, and at least one side chains at Carbon 21 and 22, such as Angeloyl groups. The compounds of the present have various pharmaceutical and therapeutic applications.

1 - 206 . (canceled) 
     
     
         207 . A method for inhibiting cancer cell growth in a subject, comprising administering to the subject an effective amount of saponins from Wenguanguo or  Xanthoceras Sorbifolia , wherein the cancer is selected from the group consisting of breast cancer, leukocyte cancer, liver cancer, ovary cancer, bladder cancer, prostate cancer, bone cancer, colon, cervix, lung and brain cancer. 
     
     
         208 . The method of  claim 207 , wherein the saponins comprise: 
       
         
           
           
               
               
           
         
         wherein R1, R2, R3 and R4 are individually attached an angeloyl, acetyl or hydrogen; wherein R5 are sugar moieties/alduronic acid of glucose, galactose and arabinose. 
       
     
     
         209 . The method of  claim 207 , wherein the saponins comprise: 
       
         
           
           
               
               
           
         
         wherein R1, R2, R3 and R4 are individually attached an angeloyl, acetyl or hydrogen; wherein R5 are sugar moieties/alduronic acid of glucose, galactose and arabinose. 
       
     
     
         210 . The method of  claim 207 , wherein the saponins comprise: 
       
         
           
           
               
               
           
         
         wherein R1, R2 are individually attached an angeloyl; R4 is H; wherein R5 are sugar moieties/alduronic acid of glucose, galactose and arabinose. 
       
     
     
         211 . The method of  claim 207 , wherein the saponins comprise: 
       
         
           
           
               
               
           
         
         wherein R1, R2 are individually attached an angeloyl, acetyl or H. 
       
     
     
         212 . The method of  claim 207 , wherein the saponins comprise: 3-O-[β-D-galactopyranosyl(1→2)]-α-L-arabinofuranosyl(1→3)-β-D-glucuronopyranosyl-21,22-O-diangeloyl-3β,15α,16α,21β,22α,28-hexahydroxyolean-12-ene, 
       
         
           
           
               
               
           
         
       
     
     
         213 . The method of  claim 207 , wherein the cancer is breast cancer. 
     
     
         214 . The method of  claim 207 , wherein the cancer is leukocyte cancer. 
     
     
         215 . The method of  claim 207 , wherein the cancer is liver cancer. 
     
     
         216 . The method of  claim 207 , wherein the cancer is ovary cancer. 
     
     
         217 . The method of  claim 207 , wherein the cancer is prostate cancer. 
     
     
         218 . The method of  claim 207 , wherein the cancer is bone cancer. 
     
     
         219 . The method of  claim 207 , wherein the cancer is brain cancer. 
     
     
         220 . The method of  claim 207 , wherein the cancer is colon cancer. 
     
     
         221 . The method of  claim 207 , wherein the cancer is cervix cancer. 
     
     
         222 . The method of  claim 207 , wherein the cancer is lung cancer. 
     
     
         223 . The method of  claim 207 , wherein the saponins are in a pharmaceutically suitable carrier.